Anti-Human WNVE Protein Therapeutic Antibody (MGAWN1)
Recombinant Humanized monoclonal antibody expressed in CHO binding to Human WNVE Protein. MGAWN1 is an investigational anti-WNV humanized monoclonal antibody being developed for the treatment of West Nile virus infections. The results of this Phase 1 study suggest that single infusions of MGAWN1 up to 30 mg/kg appear to be safe and well tolerated in healthy subjects.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-669CL |
| Pricing | Inquiry |
| Type | Antibody |
| Storage | Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples. |
| Target | WNVE Protein |
| Species Reactivity | Human |